ustekinumab 45 mg/.5mL
ustekinumab · INJECTION, SOLUTION · Janssen Biotech, Inc.
No Recall History
Plain English
ustekinumab is a injection, solution containing ustekinumab at 45 mg/.5mL, taken subcutaneous. Manufactured by Janssen Biotech, Inc..
Key Facts
- Brand Name
- ustekinumab
- Generic Name
- ustekinumab
- NDC Code (Product)
57894-440- Manufacturer
- Janssen Biotech, Inc.
- Strength
- 45 mg/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125261
- Drug Class
- Interleukin-12 Antagonist [EPC]; Interleukin-23 Antagonist [EPC]
- Marketing Start
- 04/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is ustekinumab used for?
ustekinumab contains ustekinumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is ustekinumab a controlled substance?
ustekinumab is not classified as a controlled substance by the DEA.
What is the generic name for ustekinumab?
The generic name for ustekinumab is ustekinumab. There are 12 other brand versions of ustekinumab.
What is the NDC code for ustekinumab 45 mg/.5mL?
The NDC (National Drug Code) for ustekinumab 45 mg/.5mL is 57894-440, listed by Janssen Biotech, Inc..